Profile

Virano is a genetic immunomodulation company, developing next-generation combination products which reprogram the immune system to transform the treatment of solid tumors and genetic diseases. Its approach is to rationally combine immune modulating small molecules (VEPOs™) with gene delivery and biological therapeutic elements. Virano creates efficacious therapeutic products to address unmet patient needs through internal development and partnerships.

Virano Therapeutics logo

Website

viranotx.com

Contact


Event details

Date: November 3 - 5, 2025

Event contact

Patricia Cosgrove
Area Director
USA: Life Sciences

Participants

22 in total